Article Details

Dr Sullivan on RP1 Plus Nivolumab in Anti–PD-1–Refractory Melanoma - OncLive

Retrieved on: 2025-02-12 23:40:27

Tags for this article:

Click the tags to see associated articles and topics

Dr Sullivan on RP1 Plus Nivolumab in Anti–PD-1–Refractory Melanoma - OncLive. View article details on hiswai:

Excerpt

... system in such a way that it can help [lead] to [the] attack of ... immune response. This approach aims to activate immune cells capable of ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up